Summary. HIV-1 infection keeps on being a global problem because of its pandemic character and the impossibility for eradication. The combined antiretroviral therapy (АRТ) remains the only treatment which has proven its effectiveness for maintaining the life of HIV positive patients. Because of long term (life time) duration of this therapy, it is necessary to monitor patients for possible drug toxicity. The aim of our research is to evaluate the changes of basic laboratory examinations while conducting a long-term АRТ. We analyzed basic laboratory studies of 145 HIV-infected Bulgarian patients in the current research. The patients were separated into four groups according to their treatment regimen. They were on dispensary monitoring and were being treated in the Department for Patients with Acquired Immune Defi ciency in the Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases "Prof. Ivan Kirov" -Sofi a. Our results showed that combined ART led to changes in blood count, alanin-aminotransferase (ALT), glucose and total cholesterol. Some of these changes are signifi cant for some of the drugs administered. The current ART does not lead to severe toxicity and life-threatening conditions such as those which were observed in the fi rst few years of ART introduction.
INTRODUCTION
HIV-1 infection keeps on being a global problem because of its pandemic character and the impossibility for eradication. At the moment there is not a therapeutic model available for the eradication of HIV. The combined antiretroviral therapy (ART) remains the only treatment which has proven its effectiveness for maintaining the life of the HIV positive patients. Nowadays the HIV infection has turned into a chronic
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disease with signifi cantly longer life expectancy of the patients, as long as they are on a suitable ART. The development of the ART marked one of the most dramatic inventions in the history of medicine. The objectives of the АRT include reduction of deaths and morbidity caused by HIV as well as improvement of the quality of life, the recovery and the preservation of the patient's immune function and the replication control over the HIV virus [30] . These objectives are achieved when HIV-1 RNA level is suppressed to a lower value than 20-50 copies/mL, which is determined by the limitations of current available diagnostic techniques.
There are fi ve groups of antiretroviral medicaments according to their specifi c target enzyme in HIV-replication cycle -nucleoside inhibitors of the reverse transcriptase (NRTIs), non-nucleoside inhibitors of the reverse transcriptase (NNRTIs), protease inhibitors (PIs), integrase inhibitors (IIs) and entry inhibitors (including fusion inhibitors and CCR5 antagonists). When starting ART the recommended combinations are two nucleoside inhibitors plus one non-nucleoside inhibitor (2 NRTI + 1 NNRTI) or two nucleoside inhibitors plus one protease inhibitor (2 NRTI + 1 PI) or two nucleoside inhibitors plus one integrase inhibitor (2 NRTI + 1 II).
Some studies showed that oxidative stress could be the main factor for the toxicity in the treatment with antiretroviral drugs [2, 4, 13, 23] . Damaged antioxidants and antioxidant enzymes in HIV-positive patients treated with ART were found. The toxic effects such as lipodystrophy, myopathy, cardiomyopathy, anemia, lactic acidosis, pancreatitis, and neuropathy can occur due to oxidative stress while receiving ART. Some studies found the oxidative stress as a result of highly active ART with development of the mitochondrial dysfunction [37, 40] . Other studies revealed that the combined ART itself led to increased oxidation of the proteins and an increased level of the already existing oxidative stress caused by HIVinfection [23] .
AIM OF THE STUDY
The aim of our study is to evaluate the changes of some basic laboratory parameteres -blood count, blood glucose, cholesterol, alanine aminotransferase (ALT) and creatinine while receiving a long-term ART.
MATERIAL AND METHODS
We analyzed laboratory examinations of 145 HIV-infected Bulgarian patients in the current research. The patients were separated in four groups according to their treatment regimen. They were on dispensary monitoring and were being treated in the Department for Patients with Acquired Immune Defi ciency in the Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases "Prof. Ivan Kirov" -Sofi a. The gender distribution of the patients is shown on fi gure 1. The average age of the tested subjects was 34.9 ± 9.3 years. The average age of men was 34.8 ± 9.2 years and that of the women was 35.2 ± 9.5.
Patients were monitored on an ambulatory basis. No complications requiring hospitalization were registered during the ongoing therapy. Most of the patients had ART with different continuance, but there are also untreated (naive) patients. Tests were routinely performed during the dispensary monitoring of HIV-infection in the Clinical laboratory of SHATIPD "Prof. Ivan Kirov". In order to study the infl uence of the ART by the measured laboratory parameters of the monitored patients, we divided them later into four groups: patients without treatment (naive), patients treated with Efavirenz (EFV), treated with Nevirapine (NVP) and treated with protease inhibitors. There were 35 (24.1%) patients in the fi rst group, in the second -33 (22.8%) patients, in the third -8 (5.5%) patients and in the fourth -69 (47.6%) patients. This distribution is shown in Fig. 2 . We applied one way ANOVA in order to evaluate the difference in the parameters of the tested patients. To fi nd the signifi cant differences in the tested parameters in the four groups, we did a post hoc Duncan test.
RESULTS AND DISCUSSION
The medications EFV (Efavirenz) and NVP (Nevirapine) are non-nucleoside inhibitors. In order to give a better evaluation of a possible hepatotoxic effect they are placed in different groups. According to literature data [21, 22, 34, 46, 48, 53] , more prominent hepatotoxicity is found in patients who are treated with NVP (nevirapine).
After analyzing the data from the blood count during ART we did not fi nd any signifi cant differences in the average values of the haemoglobin level. We found difference between the groups in their average values of the red blood cells (RBCs) ( Table 1) . The average count of the erythrocytes in the untreated patients was higher than in those patients who were treated with NVP and protease inhibitors (p = 0.004238). According to these results we can assume that the ART thoroughly leads to a reduction in the RBCs in the treated patients compared to the non-treated.
The common feature between the treatment regimen of the treated patients is the combination of two NRTIs. The difference between the treated patients is in the third component of the therapy. According to the literature among those who were treated with ART mainly NRTIs have suppressive effects on patients' bone marrow [28] .
In addition to these results, in 2.9% of the untreated patients, the level of the RBCs is below the lower reference interval. In the other groups -37.5% of the patients treated with NVP, 19% of the patients treated with EFV and 14.5% of the patients treated with protease inhibitors had lower RBCs level than the reference interval Anemia is a common manifestation of HIV-infection and it is an independent predictor of higher morbidity and death rate [7, 50] . In most cases anemia can be , 2013 , anemia is often associated with aging and it is also a result of chronic infl ammation during the HIV infection.
We did not fi nd any relation between the age of our patients and their hemoglobin and erythrocytes levels. Our analyses also showed that the average levels of erythrocytes of the patients treated with EFV are higher than the average levels of those treated with NVP (p = 0.003276).
While evaluating the impact of ART upon the values of the leukocyte counts we found that the average count of leukocytes of the untreated men and those treated with protease inhibitors, are signifi cantly higher than those treated with non-nucleoside inhibitors (p = 0.042414, p = 0.0301124, respectively).
The untreated patients have a preserved bone marrow function, evaluated by the normal levels of leukocytes and CD4-positive lymphocytes, thus these patients had not started ART. When comparing the protease and non-nucleoside inhibitors, according to literature data [30] it appears that the overall numbers of the leukocytes and CD4-positive cells are higher when treated with protease inhibitors compared to non-nucleoside inhibitors.
Statistical analysis revealed signifi cant differences in the average values of the platelet count, depending on ART regimen -lower platelet count in 6.6% of the EFV treated patients, in 5.4% of the naïve patients, in 1.4% of the patients treated with protease inhibitors and in 12.5% of the NVP treated ones (Table 2) . On the other hand 1.4% of the patients treated with protease inhibitors and 12.5% of those treated with NVP had higher than the upper reference interval platelet levels. The average platelet levels of the patients treated with Nevirapin were higher than the average platelet levels of the untreated patients (p = 0.032396).
This time we compared the treated and untreated patients. The treated patients have a lower viral load than the untreated.
According to a cohort study [30] the number of platelets has an inversely proportional link to the viral load of HIV. The number of platelets increases when the viral load decreases. That confi rms our results -higher platelet levels are observed in treated patients, compared to the untreated ones.
Another result of our analysis is that the average value of platelets of the treated with protease inhibitors group is higher than that of the treated with EFV patients (p = 0.039528).
This could be interpreted as an effect of a better immunological and virological response to therapy.
The average values of the platelets and the standard deviations of the different groups according to their therapy are shown in Table 2 . After analyzing the biochemical blood parameters we found signifi cant differences between the average values of ALT and cholesterol, depending on the treatment regimen. The average value of ALT in patients treated with Nevirapin is signifi cantly higher compared to those treated with PIs (p = 0.049865). The average values, standard deviations of the ALT mean level and the number and percentage of the patients with higher levels are shown in Table 3 . Higher than the reference interval levels of ALT were found in 37.5% of the patients treated with Nevirapin.
According to data from Sanne, the female gender is one of the risk factors for hepatotoxicity caused by Nevirapine [52] .
Our results showed signifi cant difference between the men treated with Nevirapin compared to the untreated and compared to those who were treated with protease inhibitors. The average level of ALT in men who were treated with Nevirapin is signifi cantly higher than the average level in the untreated and those who were treated with protease inhibitors (p = 0.009804, p = 0.005635, respectively).
Our results showed similarity with other researchers who stated that the treatment with Nevirapin is characterized by elevated liver enzymes [34, 46, 48, 56] . Other authors did not detect such effects of the Nevirapin [49] . The analyses of Torti and colleagues showed a higher risk of Nevirapin-induced toxicity in patients who are co-infected with hepatitis C [56] .
In our research, in the group of those treated with Nevirapin, 25% of the patients are co-infected with hepatitis C.
From the patients who are treated with EFV, 33.3% had increased values of ALT and 15% (n = 5) had the co-infection with hepatitis. In the group of the untreated patients 17.1% had increased values of ALT and 25.9% (n = 9) of them were coinfected with hepatitis. Ten of the patients (14.4%) treated with protease inhibitors had ALT level above the normal reference range, and 18.6% (n = 13) of them were co-infected with hepatitis.
In Table 4 there are shown the average cholesterol levels of the tested patients depending on their therapy regimen and the number and percentage of the patients with higher cholesterol levels. The average amount of the cholesterol in the group of those treated with EFV is signifi cantly higher than the average amount of the group with the untreated patients (p = 0.04986).
In this case the result of higher cholesterol could be considered as caused by the ART.
According to most studies protease inhibitors are the antiretroviral medicaments which mainly lead to deviations in the lipid profi le [29, 44, 45, 54] . Those of our patients who were treated with non-nucleoside inhibitors showed dyslipidemia in higher percentage. In the group of patients with NVP, 37.5% had cholesterol levels higher than the normal range. From the treated with EFV patients 33.3% had increased cholesterol levels, 21.7% of those treated with protease inhibitors and 5.4% of the untreated patients had increased cholesterol levels. Table 5 shows the average value of blood glucose and the number and percentages of the patients with increased blood glucose level. We found that 37.5% of the patients treated with Nevirapin and 36.9% of the patients on Efavirenz had increased levels of blood glucose, while in the group of those treated with protease inhibitors 24.6% had increased levels of blood glucose.
Protease inhibitors are considered to be the main antiretroviral medicament group which leads to glucose intolerance [29, 54] . No significant difference between the groups was found in our analyses, but we observed a higher percentage of patients treated with non-nucleoside inhibitors with higher blood glucose levels. We did not discover signifi cant differences between the average levels of creatinine in the groups on different treatment regimen.
CONCLUSION
The combined ART is the only effective way to support life among the HIVpositive patients. The current antiretroviral drugs do not lead to the same severe side effects and life-threatening conditions observed in the fi rst few years after ART introduction. However, long-term therapy requires strict monitoring not only for its therapeutic effect but also for control of the basic laboratory parameters levels which should be corrected instantly.
